Pediatric Antiretroviral Therapy (PART) Study

A longitudinal research study focused on improving care and treatment outcomes for children living with HIV in rural Zambia.

About the PART Study

The Pediatric Antiretroviral Therapy (PART) Study is a longitudinal cohort study of children infected with HIV. The study has been conducted in rural Zambia since September 2007 and focuses on understanding the challenges affecting HIV care and treatment among children.

Through long-term follow-up of children receiving HIV care, the study generates evidence that can help improve treatment outcomes, patient monitoring and the delivery of pediatric HIV services.

Study Purpose

The study seeks to better understand the care and treatment of children living with HIV in rural settings and identify factors that influence treatment outcomes.

Findings from the cohort contribute to improving approaches to pediatric HIV care and strengthening long-term patient follow-up.

Rural HIV Research

Conducting long-term research in a rural setting provides valuable insight into the realities faced by children, families and health care providers when accessing HIV services.

The research platform also provides an opportunity to evaluate changes in treatment, health outcomes and service delivery over time.

Research Areas

The PART Study provides a platform for investigating multiple aspects of pediatric HIV care, treatment and long-term health.

Study Population

The PART Study follows children receiving care for HIV in a rural Zambian setting. The cohort provides an important platform for studying pediatric HIV care across childhood and adolescence.

Longitudinal Cohort

Because participants are followed over an extended period, the study can examine changes in health, treatment and care outcomes throughout the course of follow-up.

Participant Follow-Up

Participants are followed through scheduled study visits during which information about health, treatment and clinical outcomes can be collected.

The longitudinal approach allows researchers to identify changes over time and better understand factors associated with successful HIV treatment and care.

Contribution to HIV Research

The PART Study contributes evidence on pediatric HIV treatment and care in rural African settings. Its long-term cohort structure provides an important resource for understanding health outcomes beyond short-term clinical studies.

Supporting Better Care

Research findings can help researchers, clinicians and public health programs identify opportunities to improve pediatric HIV services and treatment outcomes.

Collaboration

The PART Study is conducted through collaboration between Macha Research Trust and research partners working to improve HIV prevention, treatment and care in Zambia.

Collaboration strengthens the study's ability to generate evidence that is relevant to both local health services and broader public health priorities.

Research Ethics

Research involving children requires careful attention to ethical principles, participant safety, privacy and informed consent or appropriate parental permission and assent processes.

Participant Protection

Participant confidentiality and protection are important components of the study and its research activities.

Publications & Research Outputs

Research generated through the PART Study contributes to the scientific evidence base on pediatric HIV, treatment outcomes and health services in rural Zambia.

Learn More About Our Research

Explore the other research programs and projects conducted by Macha Research Trust.